Gene expression of non-homologous end-joining pathways in the prognosis of ovarian cancer

por Lavi, Ethan S., Lin, Z. Ping, Ratner, Elena S.
Publicado 2023

The use of QuikClot combat gauze in cervical and vaginal hemorrhage

por Vilardo, Nicole, Feinberg, Jacqueline, Black, Jonathan, Ratner, Elena
Publicado 2017

Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers

por Lin, Z. Ping, Zhu, Yong-Lian, Ratner, Elena S.
Publicado 2018

Challenging Case of Postmenopausal Bleeding and Complete Urogenital Duplication

por Grechukhina, Olga, English, Diana P., Miller, Devin, Ratner, Elena
Publicado 2016

Single application hybrid interstitial brachytherapy for cervical cancer: an institutional approach during the COVID-19 pandemic

por Damast, Shari, Tien, Christopher J., Young, Melissa, Altwerger, Gary, Ratner, Elena
Publicado 2022

GSOR10 Presentation Time: 3:15 PM: Single Implant Hybrid Interstitial Brachytherapy for Cervical Cancer during the COVID-19 Pandemic: An Institutional Approach

por Damast, Shari, Tien, Christopher J., Young, Melissa R., Altwerger, Gary, Ratner, Elena
Publicado 2021

MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib

por Whicker, Margaret E., Lin, Z. Ping, Hanna, Ruth, Sartorelli, Alan C., Ratner, Elena S.
Publicado 2016

Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer

por Qian, Jack M., Stahl, John M., Young, Melissa R., Ratner, Elena, Damast, Shari
Publicado 2017

Opsoclonus-ataxia syndrome and mature ovarian teratoma in an adolescent

por Webster, Emily M., Tymon-Rosario, Joan, D'Addario, Johanna, Zeybek, Burak, Ratner, Elena S.
Publicado 2020

Transforming Growth Factor Beta and Epithelial to Mesenchymal Transition Alter Homologous Recombination Repair Gene Expression and Sensitize BRCA Wild-Type Ovarian Cancer Cells to...

por Roberts, Cai M., Rojas-Alexandre, Mehida, Hanna, Ruth E., Lin, Z. Ping, Ratner, Elena S.
Publicado 2023

Factors Predictive of Improved Survival in Patients With Brain Metastases From Gynecologic Cancer: A Single Institution Retrospective Study of 47 Cases and Review of the Literature

por Gressel, Gregory M., Lundsberg, Lisbet S., Altwerger, Gary, Katchi, Tasleem, Azodi, Masoud, Schwartz, Peter E., Ratner, Elena S.
Publicado 2015

Surgical and oncologic outcomes in surgically treated women 80 years and older with endometrioid endometrial cancer as a function of their comorbidities

por AlAshqar, Abdelrahman, Ghazarian, Maddie, Webster, Emily M., Upadhyay, Animesh, Azodi, Masoud, Schwartz, Peter E., Ratner, Elena, Altwerger, Gary
Publicado 2023

Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma

por Pelligra, Silvia, Buza, Natalia, Hui, Pei, Bellone, Stefania, Zeybek, Burak, Ratner, Elena, Schwartz, Peter E., Scambia, Giovanni, Santin, Alessandro D.
Publicado 2020

High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma

por Damast, Shari, Higgins, Susan A., Ratner, Elena, De Leon, Maria C., Mani, Sheida, Silasi, Dan-Arin, Azodi, Masoud, Santin, Alessandro, Rutherford, Thomas, Schwartz, Peter E.
Publicado 2015

Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer

por Lin, Z. Ping, Zhu, Yong-Lian, Lo, Ying-Chun, Moscarelli, Jake, Xiong, Amy, Korayem, Yasmin, Huang, Pamela H., Giri, Smith, LoRusso, Patricia, Ratner, Elena S.
Publicado 2018

Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair

por Ratner, Elena S, Zhu, Yong-Lian, Penketh, Philip G, Berenblum, Julie, Whicker, Margaret E, Huang, Pamela H, Lee, Yashang, Ishiguro, Kimiko, Zhu, Rui, Sartorelli, Alan C, Lin, Z Ping
Publicado 2016

In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer

por Lin, Z. Ping, Al Zouabi, Nour N., Xu, Mark L., Bowen, Nicole E., Wu, Terence L., Lavi, Ethan S., Huang, Pamela H., Zhu, Yong-Lian, Kim, Baek, Ratner, Elena S.
Publicado 2021

Corrigendum to “Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutation...

por Santin, Alessandro D., Filiaci, Virginia, Bellone, Stefania, O'Cearbhaill, Roisin, Ratner, Elena S., Mathews, Cara A., Cantuaria, Guilherme, Gunderson, Camille C., Rutledge, Teresa, Buttin, Barbara M., Lankes, Heather A., Birrer, Michael J.
Publicado 2020

Financial toxicity in patients with gynecologic malignancies: a cross sectional study

por Zeybek, Burak, Webster, Emily, Pogosian, Natalia, Tymon-Rosario, Joan, Balch, Alan, Altwerger, Gary, Clark, Mitchell, Menderes, Gulden, Huang, Gloria, Azodi, Masoud, Ratner, Elena S., Schwartz, Peter E., Santin, Alessandro D., Andikyan, Vaagn
Publicado 2021

Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro

por Ferrari, Francesca, Bellone, Stefania, Black, Jonathan, Schwab, Carlton L., Lopez, Salvatore, Cocco, Emiliano, Bonazzoli, Elena, Predolini, Federica, Menderes, Gulden, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E., Santin, Alessandro D.
Publicado 2015